VJHemOnc is committed to improving our service to you

ISA 2020 | New prognostic markers in AL amyloidosis

VJHemOnc is committed to improving our service to you

Efstathios Kastritis

There has been a recent effort to increase the number of prognostics available for amyloidosis clinicians. Efstathios Kastritis, MD, University of Athens School of Medicine, Athens, Greece, talks on this and some of the new prognostic markers in AL amyloidosis such as growth differentiation factor-15 (GDF15) and D-dimers. This interview was recorded via an online conference call with. The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter